NAGE — Niagen Bioscience Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapHigh Flyer

Annual balance sheet for Niagen Bioscience, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	16.7	28.2	20.2	27.2	44.5
Net Total Accounts Receivable
Net Total Receivables	2.69	5.23	8.48	5.23	7.77
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	32.2	48.9	46.6	49.5	64.1
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	4.43	7.36	6.32	4.54	3.45
Net Intangible Assets
Other Long Term Assets
Total Assets	38.4	57.8	54.1	55	68.3
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	16.5	17.6	17.9	20.6	17.9
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	21.9	26.1	25.4	26.5	22.2
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	16.4	31.7	28.7	28.5	46.1
Total Liabilities & Shareholders' Equity	38.4	57.8	54.1	55	68.3
Total Common Shares Outstanding